Source: MarketScreener

Soligenix: Soligenix Announces Investor Webcast Event and Presentation Today: Advantages of the CiVax Program for Development of a Broadly Distributed Heat Stable COVID-19 Vaccine

(marketscreener.com) PRINCETON, N.J., Sept. 10, 2020 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, released the presentation for its Investor Webcast event today from 4:00 - 5:00 pm Eastern Time on the use of its...https://www.marketscreener.com/news/latest/Soligenix-Announces-Investor-Webcast-Event-and-Presentation-Today-Advantages-of-the-CiVax-trade-Pr--31265949/?utm_medium=RSS&utm_content=20200910

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Christopher J. Schaber's photo - President & CEO of Soligenix

President & CEO

Christopher J. Schaber

CEO Approval Rating

68/100

Soligenix develops and commercializes biotherapeutics for the treatment of gastrointestinal disorders, inflammation and oncology diseases. Read more